Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
Follow TEM
Alert me
Tempus AI, Inc. (TEM) Gross margin
Tempus AI, Inc.'s gross margin over the twelve months to 30 September 2026 was 64.5%, up 1.7 percentage points from fiscal 2025 (62.7%). That is above the Health Information Services industry median of 59.6% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 62.7% | 7.78 |
| FY2024 | 55.0% | 1.15 |
| FY2023 | 53.8% | 13.21 |
| FY2022 | 40.6% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 64.8% | 0.36 |
| Jun 2026 | 64.5% | 0.67 |
| Mar 2026 | 63.8% | (0.95) |
| Dec 2025 | 64.7% | 1.91 |
| 11 more quarters | Free account |
Gross margin against peers
| Company | Gross margin |
|---|---|
| DOCS Doximity, Inc. compare | 86.8% |
| HNGE Hinge Health Inc. compare | 84.5% |
| HTFL Heartflow, Inc. compare | 80.1% |
| VEEV Veeva Systems Inc. compare | 75.0% |
| HQY HealthEquity, Inc. compare | 71.3% |
| WAY Waystar Holding Corp. compare | 69.4% |
| TEM Tempus AI, Inc. | 64.5% |
| BTSG BrightSpring Health Services, Inc. compare | 12.5% |
| PRVA Privia Health Group, Inc. compare | 0.00% |
| Health Information Services industry median | 59.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on TEM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement